Bayer challenges India compulsory license ruling
Submitted by susan on Tue, 2012-05-15 12:40
German pharmaceutical company Bayer AG has formally lodged a challenge against a landmark Indian ruling that allowed a domestic generic drug-maker to produce a low-cost version of an anti-cancer drug for the Indian market. The appeal was filed on Friday 4 May with India's Intellectual Property Appellate Board.
Main Topic:
Attachment(s):
Mark Content Private(Internal):
External URL:
http://ictsd.org/i/news/bridgesweekly/132882/
Email Alert:
18
16
Publication Date:
09/05/2012